Hypermethylated promoter region of DR3, the death receptor 3 gene, in rheumatoid arthritis synovial cells
Open Access
- 28 February 2006
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 54 (3) , 779-787
Abstract
Objective: To examine the promoter activity and protein expression of the death receptor 3 gene DR3, a member of the apoptosis‐inducing Fas gene family, with particular reference to the methylation status of its promoter region in rheumatoid arthritis (RA).Methods: Genomic DNA was prepared from peripheral blood mononuclear cells obtained from healthy individuals and from patients with RA and synovial cells obtained from patients with RA and osteoarthritis. The methylation status of the DR3 promoter was analyzed by bisulfite genomic sequencing and methylation‐specific polymerase chain reaction techniques. Gene promoter activity and protein expression were examined using the luciferase reporter and Western blotting techniques.Results: The promoter region of the DR3 gene contained many CpG motifs, including one CpG island that was specifically hypermethylated in synovial cells from patients with RA. Promoter assays showed that the promoter CpG island was essential for the transactivation of the DR3 gene and that forced hypermethylation of the CpG island with the bacterial methylase Sss I in vitro resulted in inhibition of the DR3 gene expression. Furthermore, the expression of DR‐3 protein was down‐modulated in association with methylation of the promoter CpG island in RA synovial cells.Conclusion: The CpG island in the DR3 gene promoter was specifically methylated to down‐modulate the expression of DR‐3 protein in rheumatoid synovial cells, which may provide resistance to apoptosis in RA synovial cells.Keywords
This publication has 36 references indexed in Scilit:
- New Drugs for Rheumatoid ArthritisNew England Journal of Medicine, 2004
- Cytokine Pathways and Joint Inflammation in Rheumatoid ArthritisNew England Journal of Medicine, 2001
- Expansion or Elimination of B Cells In Vivo: Dual Roles for CD40- and Fas (CD95)-Ligands Modulated by the B Cell Antigen ReceptorCell, 1996
- Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease.Journal of Clinical Investigation, 1996
- Dominant interfering fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndromeCell, 1995
- The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic miceImmunity, 1994
- Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligandCell, 1994
- Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide.Proceedings of the National Academy of Sciences, 1993
- Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice.Proceedings of the National Academy of Sciences, 1993
- Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosisNature, 1992